These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 7867004
1. Preclinical evaluation of LU 79553: a novel bis-naphthalimide with potent antitumor activity. Bousquet PF, Braña MF, Conlon D, Fitzgerald KM, Perron D, Cocchiaro C, Miller R, Moran M, George J, Qian XD. Cancer Res; 1995 Mar 01; 55(5):1176-80. PubMed ID: 7867004 [Abstract] [Full Text] [Related]
2. Efficacy of DMP 840: a novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. McRipley RJ, Burns-Horwitz PE, Czerniak PM, Diamond RJ, Diamond MA, Miller JL, Page RJ, Dexter DL, Chen SF, Sun JH. Cancer Res; 1994 Jan 01; 54(1):159-64. PubMed ID: 8261436 [Abstract] [Full Text] [Related]
3. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ, Oberman EJ, Seweryniak KE, Atwood A, Bergeron RJ, Porter CW. Clin Cancer Res; 1995 Aug 01; 1(8):847-57. PubMed ID: 9816054 [Abstract] [Full Text] [Related]
4. Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. MacDonald JR, Muscoplat CC, Dexter DL, Mangold GL, Chen SF, Kelner MJ, McMorris TC, Von Hoff DD. Cancer Res; 1997 Jan 15; 57(2):279-83. PubMed ID: 9000568 [Abstract] [Full Text] [Related]
5. (R,R)-2,2'-[1,2-ethanediylbis[imino(1-methyl-2,1-ethanediyl)]]- bis[5-nitro-1H-benz[de]isoquinoline-1,3-(2H)-dione] dimethanesulfonate (DMP 840), a novel bis-naphthalimide with potent nonselective tumoricidal activity in vitro. Kirshenbaum MR, Chen SF, Behrens CH, Papp LM, Stafford MM, Sun JH, Behrens DL, Fredericks JR, Polkus ST, Sipple P. Cancer Res; 1994 Apr 15; 54(8):2199-206. PubMed ID: 8174127 [Abstract] [Full Text] [Related]
6. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA. Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):53-65. PubMed ID: 18931998 [Abstract] [Full Text] [Related]
7. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts. Pratesi G, De Cesare M, Carenini N, Perego P, Righetti SC, Cucco C, Merlini L, Pisano C, Penco S, Carminati P, Vesci L, Zunino F. Clin Cancer Res; 2002 Dec 15; 8(12):3904-9. PubMed ID: 12473606 [Abstract] [Full Text] [Related]
8. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR. Clin Cancer Res; 1997 Nov 15; 3(11):2063-74. PubMed ID: 9815598 [Abstract] [Full Text] [Related]
9. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA. Clin Cancer Res; 2001 May 15; 7(5):1429-37. PubMed ID: 11350914 [Abstract] [Full Text] [Related]
10. Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases. Kruczynski A, Etiévant C, Perrin D, Imbert T, Colpaert F, Hill BT. Br J Cancer; 2000 Dec 15; 83(11):1516-24. PubMed ID: 11076662 [Abstract] [Full Text] [Related]
11. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane. Igarashi K, Koga K, He Y, Shimogori T, Ekimoto H, Kashiwagi K, Shirahata A. Cancer Res; 1995 Jun 15; 55(12):2615-9. PubMed ID: 7780977 [Abstract] [Full Text] [Related]
12. Activity of bis-carbamoyloxymethyl derivatives of pyrroles and pyrrolizines against human tumor xenografts in nude mice. Anderson WK. Cancer Res; 1982 Jun 15; 42(6):2168-70. PubMed ID: 6280852 [Abstract] [Full Text] [Related]
13. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A, Iakovou K, Gikas E, Fichtner I, Fiebig HH, Kelland LR, Double JA, Bibby MC, Hendriks HR. Anticancer Res; 2004 Jun 15; 24(2B):907-19. PubMed ID: 15161044 [Abstract] [Full Text] [Related]
14. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine. Cao S, McGuire JJ, Rustum YM. Clin Cancer Res; 1999 Jul 15; 5(7):1925-34. PubMed ID: 10430100 [Abstract] [Full Text] [Related]
15. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models. Kadhim SA, Bowlin TL, Waud WR, Angers EG, Bibeau L, DeMuys JM, Bednarski K, Cimpoia A, Attardo G. Cancer Res; 1997 Nov 01; 57(21):4803-10. PubMed ID: 9354442 [Abstract] [Full Text] [Related]
16. AA1, a newly synthesized monovalent lipophilic cation, expresses potent in vivo antitumor activity. Sun X, Wong JR, Song K, Hu J, Garlid KD, Chen LB. Cancer Res; 1994 Mar 15; 54(6):1465-71. PubMed ID: 8137249 [Abstract] [Full Text] [Related]
17. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A, Gamboa G, Nasseri A, Podnos YD, Emma D, Dorion G, Rawlings L, Carpenter PM, Bustamante A, Patel J, Rideout D. Gynecol Oncol; 1996 Feb 15; 60(2):203-12. PubMed ID: 8631539 [Abstract] [Full Text] [Related]
18. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth. Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D. Cancer Chemother Pharmacol; 2007 May 15; 59(6):725-32. PubMed ID: 16967299 [Abstract] [Full Text] [Related]
19. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines. Glinsky GV, Price JE, Glinsky VV, Mossine VV, Kiriakova G, Metcalf JB. Cancer Res; 1996 Dec 01; 56(23):5319-24. PubMed ID: 8968076 [Abstract] [Full Text] [Related]
20. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts. Gourdeau H, Genne P, Kadhim S, Bibeau L, Duchamp O, Ouellet F, deMuys JM, Bouffard DY, Attardo G. Cancer Chemother Pharmacol; 2002 Dec 01; 50(6):490-6. PubMed ID: 12451476 [Abstract] [Full Text] [Related] Page: [Next] [New Search]